Urocortin 2 Gene Transfer Improves Glycemic Control and Reduces Retinopathy and Mortality in Murine Insulin Deficiency

Type 1 diabetes affects 20 million patients worldwide. Insulin is the primary and commonly the sole therapy for type 1 diabetes. However, only a minority of patients attain the targeted glucose control and reduced adverse events. We tested urocortin 2 gene transfer as single-agent therapy for insuli...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Mei Hua, Giamouridis, Dimosthenis, Lai, N. Chin, Guo, Tracy, Xia, Bing, Kim, Young Chul, Huu, Viet Anh Nguyen, Skowronska-Krawczyk, Dorota, Lantier, Louise, Bhargava, Raag, Hammond, H. Kirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965520/
https://www.ncbi.nlm.nih.gov/pubmed/31970200
http://dx.doi.org/10.1016/j.omtm.2019.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965520/
https://www.ncbi.nlm.nih.gov/pubmed/31970200
http://dx.doi.org/10.1016/j.omtm.2019.12.002

Ejemplares similares